Timolumab
Timolumab (BTT1023), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023) could be used in the study of chronic inflammatory diseases[1][2].
Product Specifications
CAS Number
1073538-99-4
Product Name Alternative
BTT 1023; Anti-Human AOC3 Recombinant Antibody
UNSPSC
12352203
Target
VAP-1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/timolumab.html
Purity
98.56
Solubility
10 mM in DMSO
Smiles
[Timolumab]
Molecular Weight
(144.44 kDa)
References & Citations
[1]Ahmad H Ali, et al. Novel treatments in primary sclerosing cholangitis. Clin Liver Dis (Hoboken) . 2016 Nov 30;8 (5) :132-135.|[2]Takayuki Inoue, et al. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. Bioorg Med Chem. 2013 Mar 1;21 (5) :1219-33.|[3]Anu Autio, et al. Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation. J Nucl Med. 2013 Aug;54 (8) :1315-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
